Trimetazidine dihydrochloride

Trimetazidine dihydrochloride is mainly used to treat angina pectoris (chest pain due to heart ischemia). It works by improving cellular energy metabolism in heart muscle cells, helping them better tolerate low oxygen conditions. It helps reduce the frequency and severity of angina attacks without affecting heart rate or blood pressure. It is also used to improve symptoms in some cases of vertigo and tinnitus related to inner ear disorders. It is grouped under the following drug class(es): Antianginals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Kyurinett, Adexor, Lubomail, Vastarel and Yosimilon. Its PubChem CID is 83201.

CAS No 13171-25-0
Molecular Formula C14H24Cl2N2O3
Molecular Weight 339.3 g/mol
Synonyms 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride

Frequently Asked Questions